| Drugs for Immune Sys |
Drugs |
Unfinished |
2018-08-21 |
eoyeba |
17 |
0 |
edit |
|
| Chapter 5 Skin Drug |
Generic and Brand |
Pharmacology |
2018-09-06 |
eoyeba |
50 |
0 |
edit |
|
| Calcium Salts and El |
Drugs |
Unfinished |
2018-09-17 |
eoyeba |
5 |
0 |
edit |
|
| Table 6.2 |
Osteoporosis Agents |
Unfinished |
2018-09-17 |
eoyeba |
12 |
0 |
edit |
|
| Commonly Used NSAIDs |
Table 6.3 |
Unfinished |
2018-09-17 |
eoyeba |
12 |
0 |
edit |
|
| Commonly Used DMARDs |
Table 6.4 |
Unfinished |
2018-09-17 |
eoyeba |
13 |
0 |
edit |
|
| Gout Agents |
Table 6.5 |
Unfinished |
2018-09-17 |
eoyeba |
7 |
0 |
edit |
|
| The Nervous System |
Drug Therapy |
Unfinished |
2018-10-16 |
eoyeba |
6 |
0 |
edit |
|
| The Nervous System |
Commonly Used AEDs |
Unfinished |
2018-10-16 |
eoyeba |
22 |
0 |
edit |
|
| The Nervous System |
Dopaminergic Drugs |
Unfinished |
2018-10-16 |
eoyeba |
5 |
0 |
edit |
|
| The Nervous System |
Anticholinergics and Amantadine |
Unfinished |
2018-10-16 |
eoyeba |
4 |
0 |
edit |
|
| The Nervous System |
COMT Inhibitor |
Unfinished |
2018-10-16 |
eoyeba |
2 |
0 |
edit |
|
| The Nervous System |
MAOIs |
Unfinished |
2018-10-16 |
eoyeba |
2 |
0 |
edit |
|
| The Nervous System |
Alzheimer's Disease Drugs |
Unfinished |
2018-10-16 |
eoyeba |
6 |
0 |
edit |
|
| The Nervous System |
ADHD |
Unfinished |
2018-10-16 |
eoyeba |
8 |
0 |
edit |
|
| The Nervous System |
Alpha Receptor Blockers |
Unfinished |
2018-10-16 |
eoyeba |
3 |
0 |
edit |
|
| The Nervous System |
Beta Blocker |
Unfinished |
2018-10-16 |
eoyeba |
15 |
0 |
edit |
|
| The Nervous System |
Adrenergic Agonists |
Unfinished |
2018-10-16 |
eoyeba |
8 |
0 |
edit |
|
| Drugs for Disorders |
Drugs SSRIs and SNRIs (ine) |
Unfinished |
2018-11-07 |
eoyeba |
9 |
0 |
edit |
|
| Drugs of Disorders |
Comon TCAs (tricyclic antidepressants) |
Unfinished |
2018-11-07 |
eoyeba |
6 |
0 |
edit |
|
| Drugs for Disorders |
Common MAOIs |
Unfinished |
2018-11-07 |
eoyeba |
3 |
0 |
edit |
|
| Drugs for Disorders |
Common Benzodiazepines |
Unfinished |
2018-11-07 |
eoyeba |
9 |
0 |
edit |
|
| Drugs for Disorders |
Common Prescription Sleep Aids |
Unfinished |
2018-11-07 |
eoyeba |
4 |
0 |
edit |
|
| Drugs for Disorders |
Typical Antipsychotics |
Unfinished |
2018-11-07 |
eoyeba |
8 |
0 |
edit |
|
| Drugs for Disorders |
Atypical Antipsychotics |
Unfinished |
2018-11-07 |
eoyeba |
7 |
0 |
edit |
|
| table 9.1 |
Drugs for Muscular, and Sensory Systems: Acetaminophen and Aspirin Analgesics |
Unfinished |
2018-11-29 |
eoyeba |
2 |
0 |
edit |
|
| table 9.2 |
table 9.2 |
Unfinished |
2018-12-06 |
eoyeba |
15 |
0 |
edit |
|
| table 9.3 |
Commonly Used Triptans |
Unfinished |
2018-11-29 |
eoyeba |
7 |
0 |
edit |
|
| table 9.4 |
Commonly Used Combination Products for Headache Pain |
Unfinished |
2018-11-29 |
eoyeba |
6 |
0 |
edit |
|
| table 9.5 |
Commonly Used General Anesthetics |
Unfinished |
2018-11-29 |
eoyeba |
13 |
0 |
edit |
|
| table 9.6 |
Commonly Used local Anesthetics |
Unfinished |
2018-11-29 |
eoyeba |
13 |
0 |
edit |
|
| Table 10.1 |
Centrally Acting Muscle Relaxants |
Unfinished |
2019-01-10 |
eoyeba |
8 |
0 |
edit |
|
| 10.2 |
Neuromuscular Blocking Agents |
Unfinished |
2019-01-10 |
eoyeba |
12 |
0 |
edit |
|
| Table 11.1 |
Ophthalmic Agents for Glaucoma |
Unfinished |
2019-01-30 |
eoyeba |
24 |
0 |
edit |
|
| Table 11.2 |
Commonly Used Ophthalmic Anti-Infectives |
Unfinished |
2019-01-30 |
eoyeba |
28 |
0 |
edit |
|
| Table 11.3 |
Commonly Used Ophthalmic Corticosteroids |
Unfinished |
2019-01-30 |
eoyeba |
7 |
0 |
edit |
|
| Stack #2962061 |
Stack #2962061 |
Unfinished |
2019-01-30 |
eoyeba |
22 |
0 |
edit |
|
| Table 11.5 |
Commonly Used Otic Antibiotics |
Unfinished |
2019-01-30 |
eoyeba |
9 |
0 |
edit |
|
| Table 11.6 |
Miscellaneous Otic Products |
Unfinished |
2019-01-30 |
eoyeba |
8 |
0 |
edit |
|
| table 11.8 |
Commonly Used Antihistamines |
Unfinished |
2019-01-30 |
eoyeba |
9 |
0 |
edit |
|
| table 11.9 |
Commonly Decongestants |
Unfinished |
2019-01-30 |
eoyeba |
2 |
0 |
edit |
|
| table 11.1 |
Commonly Used Nasal Corticosteroids |
Unfinished |
2019-01-30 |
eoyeba |
7 |
0 |
edit |
|
| Table 12.2 |
Common ACE Inhibitors |
Unfinished |
2019-02-13 |
eoyeba |
7 |
0 |
edit |
|
| Table 12.3 |
Common ARBs |
Unfinished |
2019-02-13 |
eoyeba |
7 |
0 |
edit |
|
| Table 12.4 |
Common Calcium-Channel Blockers |
Unfinished |
2019-02-13 |
eoyeba |
7 |
0 |
edit |
|
| Table 12.5 |
Antiarrhythmic Agents (Class 1Membrane-Stabilizing Agents) |
Unfinished |
2019-02-13 |
eoyeba |
7 |
0 |
edit |
|
| table 12.5 |
Antiarrhythmic Agents (Class 2 Beta Blockers) |
Unfinished |
2019-02-13 |
eoyeba |
4 |
0 |
edit |
|
| Table 12.5 |
Antiarrhythmic Agents (Class 3 Potassium-Channel Blockers) |
Unfinished |
2019-02-13 |
eoyeba |
2 |
0 |
edit |
|
| Table 12.5 |
Antiarrhythmic Agents (Class 4 Calcium-Channel Blockers) |
Unfinished |
2019-02-13 |
eoyeba |
2 |
0 |
edit |
|
| Table 12.6 |
Digoxin |
Unfinished |
2019-02-13 |
eoyeba |
1 |
0 |
edit |
|
| Table 12.7 |
Drugs Commonly Stocked in Emergency Crash Carts |
Unfinished |
2019-02-13 |
eoyeba |
22 |
0 |
edit |
|
| Table 12.8 |
Short-Acting Nitrates/Long-Acting Nitrates |
Unfinished |
2019-02-13 |
eoyeba |
5 |
0 |
edit |
|
| Table 12.9 |
Common Antihyperlipidemic Drugs |
Unfinished |
2019-02-13 |
eoyeba |
13 |
0 |
edit |
|
| Table 12.10 |
Niacin Products |
Unfinished |
2019-02-13 |
eoyeba |
4 |
0 |
edit |
|
| Table 13.1 |
Commonly Used Supplements for Anemia |
Unfinished |
2019-02-13 |
eoyeba |
7 |
0 |
edit |
|
| Table 13.2 |
Commonly Used Hematopoietic Agents |
Unfinished |
2019-02-13 |
eoyeba |
2 |
0 |
edit |
|
| Table 13.3 |
Anticoagulants |
Unfinished |
2019-02-13 |
eoyeba |
11 |
0 |
edit |
|
| Table 13.5 |
Anticoagulation Antagonists |
Unfinished |
2019-02-13 |
eoyeba |
2 |
0 |
edit |
|
| Table 13.6 |
Commonly Used Antiplatelet Agents |
Unfinished |
2019-02-13 |
eoyeba |
5 |
0 |
edit |
|
| Table 13.7 |
Commonlt Used Thrombolytic Agents |
Unfinished |
2019-02-13 |
eoyeba |
6 |
0 |
edit |
|
| Table 14.1 |
Common Short-Acting Beta Agonist |
Unfinished |
2019-02-20 |
eoyeba |
4 |
0 |
edit |
|
| Table 14.2 |
Common Inhaled Corticosteroids |
Unfinished |
2019-02-20 |
eoyeba |
9 |
0 |
edit |
|
| Table 14.3 |
Common Leukotriene Inhibitors |
Unfinished |
2019-02-20 |
eoyeba |
3 |
0 |
edit |
|
| Table 14.4 |
Common Anticholinergic Agents |
Unfinished |
2019-02-20 |
eoyeba |
3 |
0 |
edit |
|
| Table 14.5 |
Common Long-Acting Beta Agonist |
Unfinished |
2019-02-20 |
eoyeba |
2 |
0 |
edit |
|
| Table 14.6 |
Common TB Drugs |
Unfinished |
2019-02-20 |
eoyeba |
7 |
0 |
edit |
|
| Table 14.7 |
Common Smoking Cessation Products |
Unfinished |
2019-02-20 |
eoyeba |
3 |
0 |
edit |
|
| Table 15.1 |
Drugs that Can Cause Diarrhea |
Unfinished |
2019-02-20 |
eoyeba |
7 |
0 |
edit |
|
| Table 15.2 |
Commonly Used Antidiarrheal Drugs |
Unfinished |
2019-02-20 |
eoyeba |
5 |
0 |
edit |
|
| Table 15.3 |
Drugs that Can Cause Constipation |
Unfinished |
2019-02-20 |
eoyeba |
9 |
0 |
edit |
|
| Table 15.4 |
Commonly Used Laxatives |
Unfinished |
2019-02-20 |
eoyeba |
10 |
0 |
edit |
|
| Table 15.5 |
Foods and Medications that May Worsen GERD |
Unfinished |
2019-02-20 |
eoyeba |
4 |
0 |
edit |
|
| Table 15.6 |
Commonly Used Antacids |
Unfinished |
2019-02-20 |
eoyeba |
4 |
0 |
edit |
|
| Table 15.7 |
Commonly Used PPIs |
Unfinished |
2019-02-20 |
eoyeba |
5 |
0 |
edit |
|
| Table 15.8 |
Commonly Used H2 Blockers |
Unfinished |
2019-02-20 |
eoyeba |
4 |
0 |
edit |
|
| Table 15.9 |
Commonly Used Regimens for H. pylori Eradiction |
Unfinished |
2019-02-20 |
eoyeba |
10 |
0 |
edit |
|
| Table 15.10 |
Treatments that Can Cause Nausea and Vomiting |
Unfinished |
2019-02-20 |
eoyeba |
2 |
0 |
edit |
|
| Table 15.11 |
Anticholinergic Antiemetic Agents |
Unfinished |
2019-02-20 |
eoyeba |
4 |
0 |
edit |
|
| Table 15.12 |
Commonly Used General Antiemetics |
Unfinished |
2019-02-20 |
eoyeba |
5 |
0 |
edit |
|
| Table 15.13 |
Commonly Used 5-HT3 Receptor Antagonists |
Unfinished |
2019-02-20 |
eoyeba |
4 |
0 |
edit |
|
| Table 16.6 |
Common Appetite Suppressants |
Unfinished |
2019-02-26 |
eoyeba |
5 |
0 |
edit |
|
| Table 16.7 |
Lipase Inhibitors |
Unfinished |
2019-02-26 |
eoyeba |
2 |
0 |
edit |
|
| Table 17.1 |
Metformin Products |
Unfinished |
2019-02-26 |
eoyeba |
8 |
0 |
edit |
|
| Table 17.3 |
Common Insulin Secretagogues |
Unfinished |
2019-02-26 |
eoyeba |
7 |
0 |
edit |
|
| Table 17.4 |
TXDs |
Unfinished |
2019-02-26 |
eoyeba |
2 |
0 |
edit |
|
| Table 17.5 |
Incretin Therapies |
Unfinished |
2019-02-26 |
eoyeba |
6 |
0 |
edit |
|
| Table 17.6 |
Commonly Used Insulins |
Unfinished |
2019-02-26 |
eoyeba |
11 |
0 |
edit |
|
| Table 17.7 |
Common Thyroid Hormone Products |
Unfinished |
2019-02-26 |
eoyeba |
5 |
0 |
edit |
|
| Table 18.1 |
Commercially Available Female Hormone Replacement Products |
Unfinished |
2019-02-26 |
eoyeba |
9 |
0 |
edit |
|
| Table 18.3 |
Common ED Medications |
Unfinished |
2019-02-26 |
eoyeba |
7 |
0 |
edit |
|
| Table 18.4 |
Common Oral Contraceptive Agents |
Unfinished |
2019-02-26 |
eoyeba |
9 |
0 |
edit |
|
| Table 18.5 |
Transdermal and Vaginal Hormonal Contraceptives |
Unfinished |
2019-02-26 |
eoyeba |
3 |
0 |
edit |
|
| Table 16.4 |
Deficiencies and Toxicities of Common Vitamins and Minerals |
Unfinished |
2019-02-28 |
eoyeba |
22 |
0 |
edit |
|
| Table 19.1 |
Commonly Used Antispasmodics |
Unfinished |
2019-03-03 |
eoyeba |
9 |
0 |
edit |
|
| Table 19.3 |
Commonly Used Alpha Blockers |
Unfinished |
2019-03-03 |
eoyeba |
2 |
0 |
edit |
|
| Table 19.4 |
Common 5-Alpha Reductase Inhibitors |
Unfinished |
2019-03-03 |
eoyeba |
2 |
0 |
edit |
|
| Table 19.6 |
Commonly Used Diuretics |
Unfinished |
2019-03-03 |
eoyeba |
18 |
0 |
edit |
|
| Table 20.4 |
Common Electrolyte Replacement Products |
Unfinished |
2019-03-03 |
eoyeba |
16 |
0 |
edit |
|
| Table 20.5 |
Common Acidifying and Alkalinizing Products |
Unfinished |
2019-03-03 |
eoyeba |
4 |
0 |
edit |
|
| Table 21.2 |
Unique Toxicities of Chemotherapy Agents |
Unfinished |
2019-03-03 |
eoyeba |
17 |
0 |
edit |
|
| Table 21.4 |
Commonly Used Injectable Chemotherapy Drugs |
Unfinished |
2019-03-03 |
eoyeba |
33 |
0 |
edit |
|